Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
CALL
Pilgrim's Pride
PPC
$7.45B
| $8.04M | ﹤0.01% |
380,900
+17,300
| +5% | +$401K |
|
|
NE
1702
PUT
DELISTED
Noble Corporation
NE
| $8.02M | ﹤0.01% |
1,264,300
-50,000
| -4% | -$336K |
|
|
JKS
1703
PUT
JinkoSolar
JKS
$715M
| $8.01M | ﹤0.01% |
507,200
+155,700
| +44% | +$2.84M |
|
|
DVAX
1704
CALL
DELISTED
Dynavax Technologies
DVAX
| $8.01M | ﹤0.01% |
763,800
+247,900
| +48% | +$3.56M |
|
1705
CALL
DexCom
DXCM
$33.6B
| $8.01M | ﹤0.01% |
365,600
-30,000
| -8% | -$668K |
|
1706
PUT
Universal Corp
UVV
$1.16B
| $8.01M | ﹤0.01% |
137,600
+117,600
| +588% | +$6.94M |
|
|
RUSL
1707
PUT
DELISTED
Direxion Daily Russia Bull 2X Shares
RUSL
| $8M | ﹤0.01% |
228,400
+60,200
| +36% | +$2.01M |
|
1708
PUT
Edgewell Personal Care
EPC
$1.32B
| $8M | ﹤0.01% |
100,600
+16,200
| +19% | +$1.31M |
|
1709
CALL
Alaunos Therapeutics
TCRT
$4.52M
| $8M | ﹤0.01% |
9,471
+3,016
| +47% | +$2.42M |
|
|
XEC
1710
CALL
DELISTED
CIMAREX ENERGY CO
XEC
| $8M | ﹤0.01% |
59,500
-7,400
| -11% | -$928K |
|
1711
PUT
SAP
SAP
$244B
| $7.99M | ﹤0.01% |
87,400
-27,700
| -24% | -$2.38M |
|
|
HAR
1712
PUT
DELISTED
Harman International Industries
HAR
| $7.99M | ﹤0.01% |
94,600
-54,500
| -37% | -$4.47M |
|
1713
CALL
Flex
FLEX
$41.3B
| $7.97M | ﹤0.01% |
776,826
+612,278
| +372% | +$5.94M |
|
|
HOUS
1714
CALL
DELISTED
Anywhere Real Estate
HOUS
| $7.96M | ﹤0.01% |
308,000
+206,600
| +204% | +$5.73M |
|
1715
PUT
Warner Bros
WBD
$72.1B
| $7.96M | ﹤0.01% |
295,800
+154,500
| +109% | +$3.96M |
|
1716
CALL
Energous
WATT
$62.5M
| $7.95M | ﹤0.01% |
676
+393
| +139% | +$3.51M |
|
1717
PUT
Sturm, Ruger & Co
RGR
$611M
| $7.95M | ﹤0.01% |
137,600
-167,200
| -55% | -$10.6M |
|
1718
PUT
ArcelorMittal
MT
$56.2B
| $7.93M | ﹤0.01% |
437,667
+15,734
| +4% | +$279K |
|
1719
Honeywell
HON
$69.9B
| $7.93M | ﹤0.01% |
75,677
| – | – |
|
1720
Kroger
KR
$35.8B
| $7.93M | ﹤0.01% |
267,106
+67,987
| +34% | +$2.26M |
|
|
ISEE
1721
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $7.92M | ﹤0.01% |
171,800
+113,400
| +194% | +$6.4M |
|
|
HIMX
1722
PUT
Himax Technologies
HIMX
$2.41B
| $7.91M | ﹤0.01% |
920,300
+683,300
| +288% | +$6.4M |
|
1723
CALL
Under Armour Class C
UA
$2.16B
| $7.89M | ﹤0.01% |
233,100
+113,300
| +95% | +$4.09M |
|
1724
CALL
Fidelity National Information Services
FIS
$21B
| $7.89M | ﹤0.01% |
102,400
-1,500
| -1% | -$117K |
|
1725
PUT
Toll Brothers
TOL
$13.7B
| $7.89M | ﹤0.01% |
264,100
+90,600
| +52% | +$2.62M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.